110 related articles for article (PubMed ID: 24642839)
1. Primary tumor size in renal cell cancer in relation to the occurrence of synchronous metastatic disease.
Zastrow S; Phuong A; von Bar I; Novotny V; Hakenberg OW; Wirth MP
Urol Int; 2014; 92(4):462-7. PubMed ID: 24642839
[TBL] [Abstract][Full Text] [Related]
2. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
3. Metastatic potential of a renal mass according to original tumour size at presentation.
Umbreit EC; Shimko MS; Childs MA; Lohse CM; Cheville JC; Leibovich BC; Blute ML; Thompson RH
BJU Int; 2012 Jan; 109(2):190-4; discussion 194. PubMed ID: 21557795
[TBL] [Abstract][Full Text] [Related]
4. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
5. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
Lughezzani G; Jeldres C; Isbarn H; Perrotte P; Shariat SF; Sun M; Widmer H; Arjane P; Peloquin F; Pharand D; Patard JJ; Graefen M; Montorsi F; Karakiewicz PI
J Urol; 2009 Oct; 182(4):1287-93. PubMed ID: 19683281
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
[TBL] [Abstract][Full Text] [Related]
7. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses.
Kunkle DA; Crispen PL; Li T; Uzzo RG
J Urol; 2007 May; 177(5):1692-6; discussion 1697. PubMed ID: 17437785
[TBL] [Abstract][Full Text] [Related]
8. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
10. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
[TBL] [Abstract][Full Text] [Related]
11. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
13. Low local metastatic rate may widen indication of nephron-sparing surgery for renal cell carcinoma.
Xiong ZQ; Zheng J; Feng CC; Bao Y; Ding Q; Fang ZJ
Ann Diagn Pathol; 2012 Jun; 16(3):190-5. PubMed ID: 22209503
[TBL] [Abstract][Full Text] [Related]
14. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
15. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
Klatte T; Wunderlich H; Patard JJ; Kleid MD; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
BJU Int; 2007 Jul; 100(1):21-5. PubMed ID: 17433034
[TBL] [Abstract][Full Text] [Related]
17. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
[TBL] [Abstract][Full Text] [Related]
18. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
20. Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]